Neurodegeneration
Ju Lab
Yo-El Ju, MD, MSCI
Investigating how sleep and circadian rhythms influence neurodegenerative diseases. Through translational and clinical research, the lab aims to identify and treat sleep dysfunction to reduce disease burden, improve quality of life and promote healthy aging.
Kotzbauer Lab
Paul Kotzbauer, MD, PhD
Advances research on neurodegenerative diseases, focusing on Parkinson’s disease and infantile neuroaxonal dystrophy. The lab investigates alpha-synuclein aggregation, neuronal connectivity and enzyme dysfunction to develop imaging tools and treatments that slow disease progression and improve diagnosis.
Kress Lab
Geraldine Kress, PhD
Studing how the circadian system affects cognitive function during aging and Alzheimer’s disease. By investigating changes in brain physiology and behavior, the lab aims to uncover mechanisms that drive disease progression and identify strategies to improve outcomes and promote healthy aging.
Kummer Lab
Terrance T. Kummer, MD, PhD
Investigating cellular damage in traumatic brain injury and Alzheimer’s disease. With a focus on synaptic and gray matter injury, the lab uses innovative imaging techniques like SEQUIN to quantify synapse loss and explore its connection to neurodegeneration.
Lee Lab
Jin-Moo Lee, MD, PhD
Investigating how the brain heals after injury, focusing on stroke, Alzheimer’s disease and cerebral small vessel disease. Using molecular biology, neuroimaging and genomics, the lab bridges basic science and clinical care to develop therapies that promote recovery and repair.
Li Lab
Mingjie Li, MD, PhD
Developing viral vectors to improve gene delivery to neural cells for research and treatment of neurological disorders. Focusing on lentiviral and adeno-associated virus systems, the lab supports neuroscience studies by creating tools for cell culture and in vivo experiments that target disease mechanisms and therapeutic strategies.
Lucey Lab
Brendan P. Lucey, MD, MSCI, FAASM
Investigating how sleep affects the development and progression of Alzheimer’s disease. By studying sleep-related brain activity and biomarkers like amyloid-beta and tau, the lab aims to uncover how sleep can be used to detect, monitor and potentially prevent neurodegeneration.
Miller Lab
Timothy Miller, MD, PhD
Focused on developing treatments for neurodegenerative diseases like ALS and dementia. Through translational neuroscience and RNA-targeted therapies, the lab investigates genetic and molecular mechanisms to create safe, effective and personalized interventions.
Morris Lab
John Carl Morris, MD
Focused on Alzheimer’s disease and age-related neurological disorders. Led by John Morris, the lab works to improve early diagnosis, explore inherited dementia phenotypes and identify preclinical stages using biomarkers and neuroimaging.
Musiek Lab
Erik S. Musiek, MD, PhD
Studies how circadian rhythms influence neurodegenerative diseases like Alzheimer’s. By examining molecular mechanisms that regulate inflammation, oxidative stress and protein aggregation, the lab aims to uncover how the circadian clock impacts brain health and identify new therapeutic targets.